Synfacts, Table of Contents

Synfacts 2024; 20(09): 0988
DOI: 10.1055/s-0043-1773367

Innovative Drug Discovery and Development

HRO761: a First-in-Class Non-Covalent WRN Inhibitor with Synthetic Lethality in MSI Cancers

Contributor(s):

Antonia F. Stepan (Roche)

,

Seong Heon Kim (Hyundai Pharm)